Safety and Efficacy of Intravenous Ultra-high Dose Methylcobalamin Treatment for Peripheral Neuropathy: A Phase I/II Open Label Clinical Trial

Overview of attention for article published in Internal Medicine, September 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 10,296 followers.

One last reference during out IV introduction. Our NDs can explain if IV therapy will be helpful and appropriate... https://t.co/S4UUOHMzkx

RT @lorrainecleaver: Safety and efficacy of intravenous ultra-high dose methylcobalamin treatment for peripheral neuropathy: https://t.co/M…

Safety and efficacy of intravenous ultra-high dose methylcobalamin treatment for peripheral neuropathy: https://t.co/MIefi2zQan

Safety and efficacy of intravenous ultra-high dose methylcobalamin treatment for peripheral neuropathy: a phase… http://t.co/XREv2LOW7P

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.